Controlling inflammation in the elderly with BCG vaccination.
Journal
Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
25
06
2021
accepted:
06
07
2021
entrez:
5
8
2021
pubmed:
6
8
2021
medline:
10
8
2021
Statut:
epublish
Résumé
The tuberculosis vaccine BCG may protect against inflammation in the elderly as well as offer an option for protection from SARS-CoV-2 in developing countries.
Identifiants
pubmed: 34348906
pii: 7/32/eabk1668
doi: 10.1126/sciadv.abk1668
pmc: PMC8336952
pii:
doi:
Substances chimiques
BCG Vaccine
0
Types de publication
Journal Article
Review
Comment
Langues
eng
Sous-ensembles de citation
IM
Commentaires et corrections
Type : CommentOn
Informations de copyright
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
Références
Nat Rev Cardiol. 2018 Sep;15(9):505-522
pubmed: 30065258
Cell. 2021 Apr 1;184(7):1671-1692
pubmed: 33743212
Front Immunol. 2021 Mar 08;12:632478
pubmed: 33763077
RMD Open. 2021 Jan;7(1):
pubmed: 33468563
J Clin Invest. 2020 Oct 1;130(10):5591-5602
pubmed: 32692728
Semin Immunol. 2018 Oct;39:35-43
pubmed: 30007489
Lancet Microbe. 2021 Jul;2(7):e279-e280
pubmed: 33899038
Cell. 2020 Oct 15;183(2):315-323.e9
pubmed: 32941801